The PrivCo 250: Ranking the Largest Private Companies in the U.S
Dec 13, 2016 19:00 pm UTC| Business
NEW YORK, Dec. 13, 2016 -- PrivCo has just released The PrivCo 250: Ranking the Largest Private Companies in the U.S by Revenue Report. PrivCo screened through its proprietary Private Company Financial Database with...
Dec 13, 2016 18:29 pm UTC| Business
NEW YORK, Dec. 13, 2016 -- The Wall Street Journal is the #1 digital/print media brand for reach and influence in American business per the annual Erdos Morgan Purchase Influence in American Business study. Erdos ...
Energy XXI Plan of Reorganization Confirmed By Court
Dec 13, 2016 18:08 pm UTC| Business
HOUSTON, Dec. 13, 2016 -- Energy XXI Ltd (OTCMKTS:EXXIQ) (“Energy XXI” or the “Company”) today announced that the United States Bankruptcy Court for the Southern District of Texas, Houston Division has indicated that it...
Frequency Electronics Inc. Announces Approximately $7 Million in New Contract Awards
Dec 13, 2016 17:49 pm UTC| Business
MITCHEL FIELD, N.Y., Dec. 13, 2016 -- Frequency Electronics, Inc. (NASDAQ:FEIM) has received initial funding to provide special satellite payload subsystem units under three contracts aggregating approximately $7...
Life Partners Inc. Exits Bankruptcy, Begins Returning Assets to Investors
Dec 13, 2016 17:49 pm UTC| Business
WACO, Texas, Dec. 13, 2016 -- H. Thomas Moran, II, the Chapter 11 Trustee for Life Partners Holdings Inc. (LPHI), today announced that the Joint Plan of Reorganization sponsored by Moran and the Official Unsecured...
Genticel Reports Final Results of GTL001 Phase 2 Trial in HPV16/18-Infected Women
Dec 13, 2016 17:30 pm UTC| Business
No statistical difference in viral clearance between treatment and placebo groups at any time point over 2 yearsNo difference in incidence of subjects progressing to high-grade cervical lesions between groupsCompany...
MacroGenics Highlights Progress at 2016 R&D Day
Dec 13, 2016 17:30 pm UTC| Business
Advancement of HER2 franchise led by margetuximabExpansion and progression of B7-H3 franchiseIntroduction of PD-1 directed immuno-oncology franchiseClinical updates on multiple DART® studies underscore platform...